| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | -0.0059 | 0.8 |
| mRNA | lapatinib | FIMM | pan-cancer | AAC | -0.034 | 0.8 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.035 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.8 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | 0.0098 | 0.9 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.0076 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |